{"id":"https://openalex.org/W2804398079","doi":"https://doi.org/10.1177/1078155218775195","title":"Association between potential drug interactions and clinical outcomes in hematopoietic stem cell transplantations","display_name":"Association between potential drug interactions and clinical outcomes in hematopoietic stem cell transplantations","publication_year":2018,"publication_date":"2018-05-21","ids":{"openalex":"https://openalex.org/W2804398079","doi":"https://doi.org/10.1177/1078155218775195","mag":"2804398079","pmid":"https://pubmed.ncbi.nlm.nih.gov/29783907"},"language":"en","primary_location":{"id":"doi:10.1177/1078155218775195","doi":"https://doi.org/10.1177/1078155218775195","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1078155218775195","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058134019","display_name":"Ingrid APM Valverde","orcid":"https://orcid.org/0000-0003-0489-3064","observed_orcids":["https://orcid.org/0000-0003-0489-3064"]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":true,"raw_author_name":"Ingrid APM Valverde","raw_affiliation_strings":["Multiprofessional Residency Program, National Cancer Institute Jos\u00e9 Alencar Gomes da Silva, Rio de Janeiro, Brazil"],"raw_orcid":"https://orcid.org/0000-0003-0489-3064","affiliations":[{"raw_affiliation_string":"Multiprofessional Residency Program, National Cancer Institute Jos\u00e9 Alencar Gomes da Silva, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109397094","display_name":"Mario JS da Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Mario JS da Silva","raw_affiliation_strings":["Multiprofessional Residency Program, National Cancer Institute Jos\u00e9 Alencar Gomes da Silva, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multiprofessional Residency Program, National Cancer Institute Jos\u00e9 Alencar Gomes da Silva, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071164625","display_name":"Maely Pe\u00e7anha F\u00e1vero Retto","orcid":"https://orcid.org/0000-0002-5688-0495","observed_orcids":["https://orcid.org/0000-0002-5688-0495"]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Maely PF Retto","raw_affiliation_strings":["Multiprofessional Residency Program, National Cancer Institute Jos\u00e9 Alencar Gomes da Silva, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multiprofessional Residency Program, National Cancer Institute Jos\u00e9 Alencar Gomes da Silva, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5058134019"],"corresponding_institution_ids":["https://openalex.org/I4210142683"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.3647,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.59724625,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"25","issue":"5","first_page":"1105","last_page":"1111"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.7217000126838684,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.7217000126838684,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.2046000063419342,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.00989999994635582,"subfield":{"id":"https://openalex.org/subfields/3611","display_name":"Pharmacy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.9760000109672546},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.5860000252723694},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8820000290870667},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.7910000085830688},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.9390000104904175},{"id":"https://openalex.org/keywords/anti-infective-agents","display_name":"anti-infective agents","score":0.9599999785423279},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.6399999856948853},{"id":"https://openalex.org/keywords/bone-marrow-transplantation","display_name":"bone marrow transplantation","score":0.5950000286102295}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9043905735015869},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5925678014755249},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5508779883384705},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5406472682952881},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5373939275741577},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.535910427570343},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5225024819374084},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.4835641086101532},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46272674202919006},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.4502059519290924},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.44275814294815063},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.4173823297023773},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4148532450199127},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29447484016418457},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.24730032682418823},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D001938","descriptor_name":"Brazil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019172","descriptor_name":"Transplantation Conditioning","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/1078155218775195","doi":"https://doi.org/10.1177/1078155218775195","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1078155218775195","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},{"id":"pmid:29783907","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29783907","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W30445804","https://openalex.org/W1973138950","https://openalex.org/W1989264162","https://openalex.org/W1996991930","https://openalex.org/W2007019337","https://openalex.org/W2019763006","https://openalex.org/W2040886821","https://openalex.org/W2085629787","https://openalex.org/W2108751380","https://openalex.org/W2380535568","https://openalex.org/W2464687616","https://openalex.org/W2470021905","https://openalex.org/W2486427595","https://openalex.org/W2518805078","https://openalex.org/W2567664524","https://openalex.org/W2592188693"],"related_works":["https://openalex.org/W3212254492","https://openalex.org/W3174641319","https://openalex.org/W2019763006","https://openalex.org/W3212917706","https://openalex.org/W2085629787","https://openalex.org/W3172503403","https://openalex.org/W4386712161","https://openalex.org/W3182416871","https://openalex.org/W6977333919","https://openalex.org/W1979355123"],"abstract_inverted_index":{"The":[0,62,77,164],"association":[1,34,85],"of":[2,54,95,149],"anti-infective,":[3,36],"antineoplastic":[4,37],"and":[5,38,41,86,103,134,147],"immunosuppressant":[6],"drugs":[7],"makes":[8],"patients":[9,47,66,97],"undergoing":[10,71],"hematopoietic":[11],"stem":[12],"cell":[13],"transplantation":[14,72],"susceptible":[15],"to":[16,82,184],"the":[17,28,33,68,74,84,87,101,137,154,159,169,175,179],"effects":[18,44],"resulting":[19],"from":[20,48],"drug":[21,30,112],"interactions.":[22,130],"In":[23],"this":[24],"study,":[25],"we":[26],"analyzed":[27],"potential":[29,111,165],"interactions":[31,150,166],"in":[32,59,67,73,100,188],"between":[35],"immunomodulators":[39],"agents":[40],"their":[42],"clinical":[43],"presented":[45,109,177],"by":[46,178],"a":[49,55,144],"bone":[50],"marrow":[51],"transplant":[52,156,189],"service":[53],"Brazilian":[56],"hospital":[57],"specialized":[58],"cancer":[60],"treatment.":[61],"retrospective":[63],"cohort":[64],"involved":[65],"conditioning":[69,170],"phase":[70],"year":[75],"2013.":[76],"chi-square":[78],"test":[79],"was":[80,91],"used":[81],"assess":[83],"confidence":[88],"interval":[89],"considered":[90],"95%.":[92],"A":[93],"total":[94],"53":[96],"were":[98,136,172],"included":[99],"study":[102],"69.8%":[104],"(":[105,117],"p":[106,118],"=":[107],"0.004)":[108],"some":[110,122],"interaction.":[113],"Of":[114],"these,":[115],"97.3%":[116],"<":[119],"0.001)":[120],"exhibited":[121],"symptom":[123],"that":[124,151],"may":[125,152],"be":[126],"associated":[127,173],"with":[128,132,174],"these":[129],"Interactions":[131],"cyclophosphamide":[133],"cyclosporine":[135],"most":[138],"serious":[139],"effects.":[140],"There":[141],"has":[142],"been":[143],"high":[145],"frequency":[146],"variety":[148],"impair":[153],"entire":[155],"process,":[157],"putting":[158],"patient's":[160],"life":[161],"at":[162],"risk.":[163],"observed":[167],"during":[168],"period":[171],"symptoms":[176],"patients.":[180,190],"Strategies":[181],"are":[182],"needed":[183],"minimize":[185],"negative":[186],"outcomes":[187]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-06-01T00:00:00"}